Transient central precocious puberty: a new entity among the spectrum of precocious puberty?


Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
23 Oct 2021
Historique:
received: 19 03 2021
accepted: 28 08 2021
entrez: 24 10 2021
pubmed: 25 10 2021
medline: 19 1 2022
Statut: epublish

Résumé

Recently, we observed some cases of Precocious Puberty (PP) with a partial central activation of hypothalamic-pituitary-gonadal (HPG) axis that tended to normalized in 6-12 months. To evaluate the frequency of this form within the spectrum of forms of PP, we retrospectively assessed the clinical, hormonal and ultrasound characteristics of patients attending to our Center for signs of PP, between 2007 and 2017. To hypothesize some causes of this "pubertal poussée" a questionnaire about environmental data was provided to patients. 96 girls were recruited for the study and divided into three Groups. Group 1: 56 subjects with Central PP (CPP) requiring treatment with GnRH analogue; Group 2: 22 subjects with transient activation of pubertal axis, that tended to normalize, "Transient CPP"(T-CPP); Group 3: 18 subjects with Isolated Thelarche (IT). Mean age at diagnosis was 6.8 ± 1.0 years in Group 1, 5.9 ± 1.3 years in Group 2 and 5.6 ± 1.5 years in Group 3. A significant increase of diagnosis of T-CPP was observed over the study period. Significantly higher use of some homeopathic medicines and potential exposure to pesticides was reported in Group 2 vs Group 1. To our knowledge, we first reported a form defined as T-CPP, characterized by partial activation in the HPG axis normalizing over time. An increased use of homeopathic medicines and exposure to environmental pollutants in these patients was evidenced.

Identifiants

pubmed: 34688301
doi: 10.1186/s13052-021-01163-9
pii: 10.1186/s13052-021-01163-9
pmc: PMC8542285
doi:

Substances chimiques

Triptorelin Pamoate 08AN7WA2G0
Gonadotropin-Releasing Hormone 33515-09-2
Estradiol 4TI98Z838E
Luteinizing Hormone 9002-67-9
Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

210

Informations de copyright

© 2021. The Author(s).

Références

Rev Med Chil. 2003 Jan;131(1):95-110
pubmed: 12643227
Anthropol Anz. 2015;72(2):245-55
pubmed: 25806529
Acta Endocrinol (Copenh). 1990 Nov;123(5):481-6
pubmed: 2124026
Clin Endocrinol (Oxf). 2005 Feb;62(2):205-9
pubmed: 15670197
Eur J Endocrinol. 2014 Apr 10;170(5):749-58
pubmed: 24536086
Arch Dis Child. 2006 Jun;91(6):509-10
pubmed: 16714722
JAMA Pediatr. 2020 Apr 1;174(4):e195881
pubmed: 32040143
J Endocrinol Invest. 1998 Mar;21(3):180-3
pubmed: 9591214
Endocr Rev. 2003 Oct;24(5):668-93
pubmed: 14570750
Pediatrics. 2009 Apr;123(4):e752-62
pubmed: 19332438
Horm Res Paediatr. 2016;86(4):219-220
pubmed: 27631506
Front Neuroendocrinol. 2015 Jul;38:12-36
pubmed: 25592640
J Pediatr Surg. 2008 Nov;43(11):2109-11
pubmed: 18970951
Arch Pediatr Adolesc Med. 1994 Apr;148(4):369-76
pubmed: 8148936
N Engl J Med. 2008 May 29;358(22):2366-77
pubmed: 18509122
Horm Res Paediatr. 2016;86(4):233-239
pubmed: 27035145
Arch Dis Child. 1969 Jun;44(235):291-303
pubmed: 5785179
Int J Mol Sci. 2018 Jun 02;19(6):
pubmed: 29865233
J Clin Endocrinol Metab. 2004 Aug;89(8):3644-50
pubmed: 15292280
Radiology. 1984 Oct;153(1):113-6
pubmed: 6473771
Pediatrics. 2006 Aug;118(2):e391-9
pubmed: 16882780
J Clin Endocrinol Metab. 2010 Sep;95(9):4305-13
pubmed: 20554707
J Clin Endocrinol Metab. 1988 Sep;67(3):474-9
pubmed: 3137242

Auteurs

Valentina Assirelli (V)

Program of Endocrine-Metabolic Diseases, Unit of Pediatrics, University of Bologna, IRCCS- University Hospital of Bologna, Via Massarenti 11, Bologna, Italy.
Specialty School of Paediatrics - Alma Mater Studiorum, Università di Bologna, Bologna, Italy.

Federico Baronio (F)

Program of Endocrine-Metabolic Diseases, Unit of Pediatrics, University of Bologna, IRCCS- University Hospital of Bologna, Via Massarenti 11, Bologna, Italy.

Rita Ortolano (R)

Program of Endocrine-Metabolic Diseases, Unit of Pediatrics, University of Bologna, IRCCS- University Hospital of Bologna, Via Massarenti 11, Bologna, Italy.

Giulio Maltoni (G)

Program of Endocrine-Metabolic Diseases, Unit of Pediatrics, University of Bologna, IRCCS- University Hospital of Bologna, Via Massarenti 11, Bologna, Italy.

Stefano Zucchini (S)

Program of Endocrine-Metabolic Diseases, Unit of Pediatrics, University of Bologna, IRCCS- University Hospital of Bologna, Via Massarenti 11, Bologna, Italy.

Valeria Di Natale (V)

Program of Endocrine-Metabolic Diseases, Unit of Pediatrics, University of Bologna, IRCCS- University Hospital of Bologna, Via Massarenti 11, Bologna, Italy.

Alessandra Cassio (A)

Program of Endocrine-Metabolic Diseases, Unit of Pediatrics, University of Bologna, IRCCS- University Hospital of Bologna, Via Massarenti 11, Bologna, Italy. alessandra.cassio@unibo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH